91ÑÇÉ«´«Ã½

Maria Fe Lanfranco’s scientific career has crisscrossed the Western Hemisphere.

Born in Lima, Peru, she moved to the United States after college. “That was a big decision,” she said, “but … if I really wanted to pursue a career in science, I needed to do a Ph.D. outside Peru.” In the years since then, she has lived and worked all over the United States.

Courtesy of Maria Fe Lanfranco

Maria Fe Lanfranco studied allostery in a bacterial transcription factor.

Lanfranco won a 2018 Journal of Biological Chemistry/Herbert Tabor Young Investigator Award for her work on allostery in an E. coli transcription factor carried out as a postdoc at Georgetown University.

With colleagues, she developed an approach to understand how communication across ligand binding sites affects this protein. She in JBC in February 2017.

She credits her high school biology teacher with making it “almost a no-brainer” to study science in college.

“I’ve always been interested in identifying targets for the treatment of pathological disorders,” she said. Curiosity about the neuroscience of addiction drew Lanfranco to graduate work in the laboratory of Kathryn Cunningham at the University of Texas Medical Branch in Galveston, where she studied a serotonin receptor involved in cocaine addiction.

She followed her passion for understanding disease to a postdoctoral position studying signaling ethanol addiction with Dorit Ron at the University of California, San Francisco.

She lived in Berkeley and took a yoga teacher training course. “I started doing yoga because I was feeling stressed out — like every student in graduate school,” she said with a chuckle. A compelling teacher in Texas had gotten her more involved. In Berkeley, where she passed a yoga studio every few blocks, Lanfranco later began to teach classes herself.

With her husband, biophysicist Rodrigo Maillard, Lanfranco moved to Washington, D.C., to start his lab at Georgetown. The pair, both originally from Lima, had met in college and married as postdocs.

When Maillard started his lab, he pitched an allostery project to Lanfranco. She was interested in the neuropharmacology angle. To her, allosteric modulators are “a very provocative kind of drug, because it’s more interesting to modulate the activity of a receptor, rather than turning it on or off.”

After years of working in parallel, Lanfranco said, collaborating with Maillard works because “we complement each other a lot ... but we kind of set some rules in which we wouldn’t talk about work at home, because then it would be too much.”

Reflecting on her peripatetic pursuit of science, Lanfranco projects a yogic satisfaction: “All of those cities (Lima, Galveston, Berkeley and Washington) have a lot to offer … each one of them, at that particular time in my life, was the perfect place to be.”